Sensus Healthcare, Inc.

Sensus Healthcare, Inc.

SRTSยทNASDAQ

$3.09

-2.8%
HealthcareMedical - Devices

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

At a Glance

Live Snapshot
Market Cap$50.87M
EPS-0.4700
P/E Ratio-8.42
Earnings Date07/30/2026
3Y-137.0%
5Y-222.0%
10Y-162.0%
3Y-101.0%
5Y-103.0%
10Y-98.0%
3Y-87.0%
5Y-245.0%
10Y-104.0%
SRTS

Sensus Healthcare, Inc. Cash Conversion Engine

SRTS ยท NASDAQ
Net Income-7.72M
Depreciation & Amortization0.00
Stock-Based Compensation295.00K
Change in Working Capital8.66M
Others-709.00K
Capital Expenditures-196.00K
Free Cash Flow332.00K

Cash Flow Quality Analysis

FCF Conversion Rate

-4.3%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

37.1%

Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.

FCF Growth Trend

+130.0%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$8.66M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Sensus Healthcare, Inc. Cash Flow Statement

SRTS โ€ข NASDAQ

Sensus Healthcare, Inc. Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012
OPERATING ACTIVITIES
-7.7M
6.6M
485K
24.2M
4.1M
-6.8M
-1.7M
-2M
-3.7M
-346.4K
-237.3K
-3.7M
107.6K
-177K
0.0
432K
461K
509K
613K
721.9K
545.7K
658.3K
387.9K
337.6K
315.6K
272.6K
265.6K
177.3K
0.0
-57K
-427K
-1.7M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
295K
323K
328K
187K
415K
0.0
620.9K
982.6K
405.9K
726.4K
6.5K
6.5K
1.1K
0.0
-709K
378K
568K
-11.7M
705K
118.2K
728.9K
108.5K
429K
3M
34.5K
168K
191.8K
255.6K
(0.0)
(2.6M)
(1.4M)
(4.6M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
8.7M
-8.6M
-3.6M
-12.9M
-6.1M
5.6M
-2.3M
-8.3M
-568.9K
-4.6M
-1.5M
1.4M
-694.7K
-689.4K
528K
-831K
-2.1M
-1.4M
-286K
-434.2K
-2.1M
-8.6M
-3.1M
-851K
-1.3M
-1.9M
-128.7K
255.9K
INVESTING ACTIVITIES
-196K
-276K
-229K
-159K
-128K
-358.5K
-400.6K
-854.8K
-287.6K
-286K
-196.2K
-124K
-251K
-143.4K
(0.0)
(0.0)
(0.0)
(15M)
(257K)
(0.0)
(4.9B)
(2.6B)
(0.0)
(7.9M)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-7.8M
-2.9M
(0.0)
-7.9M
(0.0)
(0.0)
(0.0)
(0.0)
0.0
0.0
0.0
0.0
0.0
7.4M
3.3M
1.1M
6.5M
299.5K
0.0
0.0
0.0
0.0
0.0
0.0
42K
0.0
0.0
0.0
-4.9B
-2.6B
6.5M
-7.9M
0.0
0.0
0.0
0.0
-196K
-276K
-187K
(14.8M)
(129K)
(7M)
-4.9M
-2.6M
(6.2M)
-7.9M
-196.2K
-124K
-251K
-143.4K
FINANCING ACTIVITIES
-300K
67K
-27K
-3M
-15K
560.0
0.0
17.2M
0.0
12.7M
2.2M
0.0
3.6M
0.0
0.0
0.0
0.0
-51K
-216K
266.8K
0.0
-2.2M
2.2M
-422.7K
47.7K
0.0
0.0
0.0
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-2.6M
(0.0)
-45.4K
(0.0)
(0.0)
-300K
(0.0)
-27K
-3M
-15K
(0.0)
-118.8K
(0.0)
-289.3K
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-5K
-52K
-13K
622K
0.0
-57.3K
2.6M
-1.4M
-289.3K
-994K
-185.8K
0.0
-329.1K
2.1M
-305K
15K
-40K
-2.4M
-231K
210K
2.6M
13.6M
1.9M
8.7M
2.1M
-45.4K
3.2M
2.1M
CASH FLOW SUMMARY
27K
-1.1M
-2.4M
11M
-388K
6.8M
-4.4M
2.4M
5M
-22.6K
526.4K
-2M
2.9M
2.2M
22.1M
23.1M
25.5M
14.5M
14.9M
8.1M
12.5M
10.1M
5M
5.1M
4.5M
6.6M
3.7M
1.5M
22.1M
22.1M
23.1M
25.5M
14.5M
14.9M
8.1M
12.5M
10.1M
5M
5.1M
4.5M
6.6M
3.7M
332K
-1.1M
-2.4M
-1.6M
-414K
-792.7K
-2.5M
-9.4M
-3.3M
-1.1M
-1.5M
-2M
-379.7K
112.5K

SEC Filings

SRTS - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

June 02, 2026
May 29, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 13, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 29, 2026
May 29, 2026
2026
10-K

10-K 2025 FY

FY

March 04, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 12, 2026
February 12, 2026
2026
8-K

8-K 2026

N/A

January 20, 2026
January 13, 2026
2026
8-K

8-K 2026

N/A

January 12, 2026
January 05, 2026
2026
8-K

8-K 2025

N/A

November 13, 2025
November 10, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 12, 2025
September 30, 2025
2025
Showing 1 to 10 of 137 filings